Myomo® Extends and Strengthens its Global MyoPro™ Patent Portfolio

New Multi-joint Patents in both U.S. and Europe

CAMBRIDGE, Mass. (August 26, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced additional intellectual property protection with the issuance of new patents in the U.S. and Europe related to MyoPro™, its unique wearable robotic brace for arm and hand paralysis. Read more.